DarioHealth and Beluga Partner to Transform Digital Chronic Care
NEW YORK, June 29, 2026 DarioHealth Corp. has announced a strategic collaboration with Beluga Health to create a provider-backed,...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
NEW YORK, June 29, 2026 DarioHealth Corp. has announced a strategic collaboration with Beluga Health to create a provider-backed,...
NEW YORK & WESTFIELD, N.J., June 29, 2026 Talawar Therapeutics has announced a definitive business combination agreement with JATT...
KIRKLAND, Quebec, Canada & SHANGHAI, China, June 23, 2026 Organon Canada and Shanghai Henlius Biotech have expanded access to...
